Survey of Oncology Nurses Reveals Need for Knowledge Regarding Genetic Evaluation and LGBTQIA+ Cancer Care

In May of 2022, i3 Health conducted a survey of 230 oncology nurses at the Oncology Nursing Society (ONS) 47th Annual Congress in Anaheim, California, to assess nurses' familiarity and desire to understand genetic evaluation and counseling and LGBTQIA+ cancer care. Genetic evaluation and counseling are ways for patients to better understand their genome and how their DNA might be able to warn them, and even their family, about their risks to certain cancers and diseases. There are a variety of t...

Continue reading

You’re Invited! Special Event: Diagnosis and Evidence-Based Management of T-Cell Lymphoma

i3 Health would like to cordially invite you to our upcoming event, Diagnosis and Evidence-Based Management of T-Cell Lymphoma, a live CME/NCPD-approved webinar. Due to high demand, we are pleased to offer two dates and times for this expert-led discussion: Monday, June 13, 2022, at 3:00 PM EDT, and Friday, June 17, 2022, at 12:00 PM EDT. T-cell lymphoma (TCL) is an uncommon subtype accounting for approximately 15% of all cases of non-Hodgkin lymphoma in the United States. The clinical and patho...

Continue reading

CAR T-Cell Therapy: Oncology Nurses’ Educational Needs

Pre-activity assessment data from i3 Health's nursing continuing professional development (NCPD) activity "Understanding and Optimizing CAR T-Cell Therapy for Patients With B-Cell Malignancies" has revealed significant baseline knowledge gaps regarding the use of chimeric antigen receptor (CAR) T-cell therapy for the treatment of patients with B-cell malignancies. Of the 584 learners who took the pretest and began the activity, 539 saw it through to completion. The learners who completed the act...

Continue reading

Urologists Prefer Live CME Activities Over Online

At the 67th Society of Government Service Urologists (SGSU) Kimbrough Urological Seminar, held from January 15th to 19th, 2020, in Charlotte, North Carolina, i3 Health conducted a survey of participants regarding the formats in which they wished to receive continuing medical education (CME). Thirty-six individuals completed the survey, of whom 35 (97.2%) were physicians and other prescribers of medication. Results showed that despite the ever-increasing ubiquity of technology in our society, uro...

Continue reading

Learning Needs: Checkpoint Inhibitors in Cervical Cancer

Pre-activity assessment data from i3 Health's continuing medical education (CME)/continuing nursing education (CNE) activity "Optimizing the Management of Advanced Cervical Cancer With Checkpoint Inhibitor Therapy" has revealed significant baseline knowledge gaps in the area of checkpoint inhibitor therapies for advanced cervical cancer. Three hundred and ninety-seven learners took part in the educational activity and completed the pre-activity assessment, and 375 of these finished the activity ...

Continue reading

Copyright © 2022 Oncology Data Advisor. All rights reserved.